229 related articles for article (PubMed ID: 24266509)
1. In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application.
Dasgupta S; Ghosh SK; Ray S; Kaurav SS; Mazumder B
Curr Drug Deliv; 2014; 11(1):132-8. PubMed ID: 24266509
[TBL] [Abstract][Full Text] [Related]
2. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
[TBL] [Abstract][Full Text] [Related]
3. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
[TBL] [Abstract][Full Text] [Related]
4. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation.
El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB
Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177
[TBL] [Abstract][Full Text] [Related]
5. Topical delivery of aceclofenac as nanoemulsion comprising excipients having optimum emulsification capabilities: preparation, characterization and in vivo evaluation.
Dasgupta S; Dey S; Choudhury S; Mazumder B
Expert Opin Drug Deliv; 2013 Apr; 10(4):411-20. PubMed ID: 23316798
[TBL] [Abstract][Full Text] [Related]
6. Investigation of true nanoemulsions for transdermal potential of indomethacin: characterization, rheological characteristics, and ex vivo skin permeation studies.
Shakeel F; Ramadan W; Ahmed MA
J Drug Target; 2009 Jul; 17(6):435-41. PubMed ID: 19527114
[TBL] [Abstract][Full Text] [Related]
7. Transdermal Lipid Nanocarriers: A Potential Delivery System for Lornoxicam.
Dasgupta S; Ray S; Dey S; Pal P; Mazumder B
Pharm Nanotechnol; 2017; 5(1):32-43. PubMed ID: 28948909
[TBL] [Abstract][Full Text] [Related]
8. Optimization of nutraceutical coenzyme Q10 nanoemulsion with improved skin permeability and anti-wrinkle efficiency.
El-Leithy ES; Makky AM; Khattab AM; Hussein DG
Drug Dev Ind Pharm; 2018 Feb; 44(2):316-328. PubMed ID: 29096550
[TBL] [Abstract][Full Text] [Related]
9. Formulation Optimization and In-vitro and In-vivo Evaluation of Lornoxicam Ethosomal Gels with Penetration Enhancers.
Li K; Gao S; Tian B; Shi Y; Lv Q; Han J
Curr Drug Deliv; 2018; 15(3):424-435. PubMed ID: 29219057
[TBL] [Abstract][Full Text] [Related]
10. Omega 3 fatty acid-enriched nanoemulsion of thiocolchicoside for transdermal delivery: formulation, characterization and absorption studies.
Kumar D; Ali J; Baboota S
Drug Deliv; 2016; 23(2):591-600. PubMed ID: 24892633
[TBL] [Abstract][Full Text] [Related]
11. Investigating the potential of employing bilosomes as a novel vesicular carrier for transdermal delivery of tenoxicam.
Al-Mahallawi AM; Abdelbary AA; Aburahma MH
Int J Pharm; 2015 May; 485(1-2):329-40. PubMed ID: 25796122
[TBL] [Abstract][Full Text] [Related]
12. Development and optimization of nanoemulsion based gel for enhanced transdermal delivery of nitrendipine using box-behnken statistical design.
Sharma A; Singh AP; Harikumar SL
Drug Dev Ind Pharm; 2020 Feb; 46(2):329-342. PubMed ID: 31976777
[No Abstract] [Full Text] [Related]
13. Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation.
Shahzad Y; Khan Q; Hussain T; Shah SN
Int J Biol Macromol; 2013 Oct; 61():26-32. PubMed ID: 23827761
[TBL] [Abstract][Full Text] [Related]
14. Effect of high-pressure homogenization on formulation of TPGS loaded nanoemulsion of rutin - pharmacodynamic and antioxidant studies.
Sharma S; Sahni JK; Ali J; Baboota S
Drug Deliv; 2015; 22(4):541-51. PubMed ID: 24625264
[TBL] [Abstract][Full Text] [Related]
15. Proniosomal gel for transdermal delivery of lornoxicam: optimization using factorial design and in vivo evaluation in rats.
Shah H; Nair AB; Shah J; Bharadia P; Al-Dhubiab BE
Daru; 2019 Jun; 27(1):59-70. PubMed ID: 30701460
[TBL] [Abstract][Full Text] [Related]
16. Preparation and pharmacokinetics evaluation of oral self-emulsifying system for poorly water-soluble drug Lornoxicam.
Li F; Song S; Guo Y; Zhao Q; Zhang X; Pan W; Yang X
Drug Deliv; 2015; 22(4):487-98. PubMed ID: 24524289
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of eugenol nanoemulsion as a topical delivery system.
Esmaeili F; Rajabnejhad S; Partoazar AR; Mehr SE; Faridi-Majidi R; Sahebgharani M; Syedmoradi L; Rajabnejhad MR; Amani A
Pharm Dev Technol; 2016 Nov; 21(7):887-893. PubMed ID: 26365132
[TBL] [Abstract][Full Text] [Related]
18. Niosomal gel of lornoxicam for topical delivery: in vitro assessment and pharmacodynamic activity.
Kumbhar D; Wavikar P; Vavia P
AAPS PharmSciTech; 2013 Sep; 14(3):1072-82. PubMed ID: 23818079
[TBL] [Abstract][Full Text] [Related]
19. A QUALITY BY DESIGN APPROACH: FABRICATION, CHARACTERIZATION AND EVALUATION OF OPTIMIZED TRANSDERMAL THERAPEUTIC SYSTEM FOR ANTIRHEUMATIC LORNOXICAM.
Naeem M; Pervaiz F; Nawaz Z; Yousup M; Ali A; Khalid N; Khan JA
Acta Pol Pharm; 2017 Jan; 74(1):249-266. PubMed ID: 29474780
[TBL] [Abstract][Full Text] [Related]
20. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation.
Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ
Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
